News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,049 Results
Type
Article (13761)
Company Profile (101)
Press Release (251187)
Section
Business (88042)
Career Advice (465)
Deals (15342)
Drug Delivery (67)
Drug Development (36600)
Employer Resources (49)
FDA (6288)
Job Trends (6196)
News (150206)
Policy (14025)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (32)
Alliances (23212)
ALS (36)
Alzheimer's disease (384)
Antibody-drug conjugate (ADC) (35)
Approvals (6325)
Artificial intelligence (101)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (40)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (74)
Cancer (573)
Cardiovascular disease (67)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (82)
Cervical cancer (4)
Clinical research (30854)
Collaboration (321)
Compensation (131)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (112)
Cystic fibrosis (35)
Data (586)
Denatured (15)
Depression (9)
Diabetes (77)
Diagnostics (1316)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32049)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37371)
Executive appointments (346)
FDA (6674)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (203)
Gene editing (37)
Generative AI (8)
Gene therapy (98)
GLP-1 (336)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3562)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (43)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (177)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (76)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (141)
MASH (31)
Medical device (1274)
Medtech (1276)
Mergers & acquisitions (9653)
Metabolic disorders (246)
Multiple sclerosis (18)
NASH (14)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (546)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (667)
Now hiring (7)
Obesity (140)
Opinion (118)
Ovarian cancer (21)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (7)
Patents (102)
Patient recruitment (28)
Peanut (10)
People (28852)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8030)
Phase II (13054)
Phase III (11716)
Pipeline (381)
Podcasts (46)
Policy (58)
Postmarket research (1401)
Preclinical (3206)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (156)
Real estate (2633)
Recruiting (17)
Regulatory (10077)
Reports (14)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (6)
Schizophrenia (33)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (680)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6748)
Vaccines (149)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (36)
Last 7 days (212)
Last 30 days (882)
Last 365 days (12075)
2025 (2894)
2024 (12501)
2023 (14246)
2022 (19556)
2021 (20070)
2020 (19034)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15474)
2014 (12422)
2013 (10594)
2012 (11396)
2011 (11922)
2010 (10890)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (53)
Arkansas (3)
Asia (20083)
Australia (2602)
California (1612)
Canada (866)
China (226)
Colorado (65)
Connecticut (65)
Delaware (51)
Europe (39345)
Florida (299)
Georgia (35)
Idaho (9)
Illinois (181)
India (14)
Indiana (128)
Iowa (1)
Japan (85)
Kansas (55)
Kentucky (12)
Maine (2)
Maryland (245)
Massachusetts (1385)
Michigan (27)
Minnesota (89)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (701)
New Mexico (7)
New York (467)
North Carolina (375)
North Dakota (2)
Northern California (667)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (407)
Puerto Rico (8)
Rhode Island (7)
South America (501)
South Carolina (2)
Southern California (680)
Tennessee (34)
Texas (216)
Utah (33)
Virginia (69)
Washington D.C. (29)
Washington State (110)
Wisconsin (14)
265,049 Results for "terns pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors
February 21, 2025
·
4 min read
Press Releases
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
February 25, 2025
·
3 min read
Press Releases
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
March 20, 2025
·
10 min read
Press Releases
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Press Releases
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
February 26, 2025
·
10 min read
Biotech Bay
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN) today announced that members of senior management will be participating in a virtual fireside chat at UBS Obesity Therapeutics Day on Thursday, May 23, 2024 at 1:00 p.m. ET.
May 17, 2024
·
1 min read
Biotech Bay
Terns Pharmaceuticals to Participate in Upcoming June 2024 Investor Conferences
Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in June.
May 30, 2024
·
1 min read
Press Releases
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia
December 3, 2024
·
11 min read
Biotech Bay
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for TERN-701 for the treatment of chronic myeloid leukemia (CML).
March 11, 2024
·
1 min read
1 of 26,505
Next
